|
AHNAK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.857200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.239400E-01 |
| Normal-vs-Stage2 |
1.132010E-01 |
| Normal-vs-Stage3 |
2.329800E-02 |
| Normal-vs-Stage4 |
5.544100E-02 |
| Stage1-vs-Stage2 |
3.037700E-02 |
| Stage1-vs-Stage3 |
2.577800E-04 |
| Stage1-vs-Stage4 |
6.016200E-03 |
| Stage2-vs-Stage3 |
7.273200E-01 |
| Stage2-vs-Stage4 |
8.673400E-01 |
| Stage3-vs-Stage4 |
8.504800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.877000E-01 |
| Normal-vs-AfricanAmerican |
5.977200E-01 |
| Normal-vs-Asian |
9.170800E-01 |
| Caucasian-vs-AfricanAmerican |
9.712800E-01 |
| Caucasian-vs-Asian |
6.833400E-01 |
| AfricanAmerican-vs-Asian |
7.400400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.025200E-01 |
| Normal-vs-Female |
2.013800E-01 |
| Male-vs-Female |
2.957400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.269000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.311800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.329800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.023500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.259000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.019400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.533800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.453600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.392400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.287950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.629780E-02 |
| Normal-vs-Grade 2 |
6.357800E-01 |
| Normal-vs-Grade 3 |
2.566000E-01 |
| Normal-vs-Grade 4 |
1.102220E-03 |
| Grade 1-vs-Grade 2 |
6.847800E-02 |
| Grade 1-vs-Grade 3 |
6.277800E-03 |
| Grade 1-vs-Grade 4 |
1.035050E-04 |
| Grade 2-vs-Grade 3 |
3.985600E-02 |
| Grade 2-vs-Grade 4 |
1.237640E-04 |
| Grade 3-vs-Grade 4 |
1.120180E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.628600E-01 |
| Normal-vs-ccB subtype |
1.676650E-01 |
| ccA subtype-vs-ccB subtype |
1.921690E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.862960E-01 |
| Normal-vs-N1 |
3.730800E-01 |
| N0-vs-N1 |
6.062000E-01 |
|
|
